Details
Stereochemistry | ACHIRAL |
Molecular Formula | C7H16N2O |
Molecular Weight | 144.2147 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCNCC(N)=O
InChI
InChIKey=GJNNXIYZWIZFRH-UHFFFAOYSA-N
InChI=1S/C7H16N2O/c1-2-3-4-5-9-6-7(8)10/h9H,2-6H2,1H3,(H2,8,10)
Molecular Formula | C7H16N2O |
Molecular Weight | 144.2147 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Milacemide, a prodrug for glycine, is an inhibitor of the B form of monoamine oxidase. This drug could enhance dopaminergic activity in the brain and could be used as therapy for Parkinson's disease. Milacemide participated in clinical trials as a treatment for senile dementia of the Alzheimer type (SDAT). However, results have shown the drug was not an effective treatment in enhancing cognition in SDAT patients. In addition, milacemide has been tested for antiepileptic efficacy; however, this study was discontinued.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B. | 1989 Oct |
|
Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat. | 1998 Jul |
|
Safinamide for the treatment of Parkinson's disease, epilepsy and restless legs syndrome. | 2007 Jul |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1634705
1200 mg/day milacemide treatment for 1 month (113 patients received milacemide, and 115 patients received placebo
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:26:27 GMT 2023
by
admin
on
Fri Dec 15 15:26:27 GMT 2023
|
Record UNII |
0HXT24RECU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C039332
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
SUB08960MIG
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
76990-56-2
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
5266
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
C81467
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
100000080631
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
MILACEMIDE
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
CHEMBL75838
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
DTXSID10227786
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
0HXT24RECU
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY | |||
|
53569
Created by
admin on Fri Dec 15 15:26:27 GMT 2023 , Edited by admin on Fri Dec 15 15:26:27 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE ACTIVE -> PRODRUG |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|